Standard BioTools Inc.
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $25.4M |
| Cost of Revenue | $11.5M |
| Gross Profit | $13.9M |
| Gross Margin | 54.8% |
| Operating Expenses | |
| Research & Development | $12.3M |
| SG&A Expense | $19.6M |
| Operating Income | $-18.0M |
| Operating Margin | -71.0% |
| Interest Expense | $2.9M |
| Pretax Income | $-19.2M |
| Income Tax Expense | $-50.0K |
| Net Income | $-19.1M |
| Net Margin | -75.3% |
| EPS (Basic) | $-2.76 |
| EPS (Diluted) | $-2.76 |
| Shares Outstanding (Basic) | — |
| Shares Outstanding (Diluted) | — |
| Dividends Per Share | — |